713 related articles for article (PubMed ID: 12119361)
1. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H
J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.
Hama K; Aoki J; Fukaya M; Kishi Y; Sakai T; Suzuki R; Ohta H; Yamori T; Watanabe M; Chun J; Arai H
J Biol Chem; 2004 Apr; 279(17):17634-9. PubMed ID: 14744855
[TBL] [Abstract][Full Text] [Related]
3. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.
Ferry G; Tellier E; Try A; Grés S; Naime I; Simon MF; Rodriguez M; Boucher J; Tack I; Gesta S; Chomarat P; Dieu M; Raes M; Galizzi JP; Valet P; Boutin JA; Saulnier-Blache JS
J Biol Chem; 2003 May; 278(20):18162-9. PubMed ID: 12642576
[TBL] [Abstract][Full Text] [Related]
4. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.
Kishi Y; Okudaira S; Tanaka M; Hama K; Shida D; Kitayama J; Yamori T; Aoki J; Fujimaki T; Arai H
J Biol Chem; 2006 Jun; 281(25):17492-17500. PubMed ID: 16627485
[TBL] [Abstract][Full Text] [Related]
5. Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate.
Song J; Clair T; Noh JH; Eun JW; Ryu SY; Lee SN; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW
Biochem Biophys Res Commun; 2005 Nov; 337(3):967-75. PubMed ID: 16219296
[TBL] [Abstract][Full Text] [Related]
6. Submucosal connective tissue-type mast cells contribute to the production of lysophosphatidic acid (LPA) in the gastrointestinal tract through the secretion of autotaxin (ATX)/lysophospholipase D (lysoPLD).
Mori K; Kitayama J; Aoki J; Kishi Y; Shida D; Yamashita H; Arai H; Nagawa H
Virchows Arch; 2007 Jul; 451(1):47-56. PubMed ID: 17554559
[TBL] [Abstract][Full Text] [Related]
7. Lysophospholipids in the limelight: autotaxin takes center stage.
Moolenaar WH
J Cell Biol; 2002 Jul; 158(2):197-9. PubMed ID: 12135981
[TBL] [Abstract][Full Text] [Related]
8. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase.
Tokumura A; Majima E; Kariya Y; Tominaga K; Kogure K; Yasuda K; Fukuzawa K
J Biol Chem; 2002 Oct; 277(42):39436-42. PubMed ID: 12176993
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.
van Meeteren LA; Ruurs P; Christodoulou E; Goding JW; Takakusa H; Kikuchi K; Perrakis A; Nagano T; Moolenaar WH
J Biol Chem; 2005 Jun; 280(22):21155-61. PubMed ID: 15769751
[TBL] [Abstract][Full Text] [Related]
10. Regulation and biological activities of the autotaxin-LPA axis.
van Meeteren LA; Moolenaar WH
Prog Lipid Res; 2007 Mar; 46(2):145-60. PubMed ID: 17459484
[TBL] [Abstract][Full Text] [Related]
11. Expression, regulation and function of autotaxin in thyroid carcinomas.
Kehlen A; Englert N; Seifert A; Klonisch T; Dralle H; Langner J; Hoang-Vu C
Int J Cancer; 2004 May; 109(6):833-8. PubMed ID: 15027116
[TBL] [Abstract][Full Text] [Related]
12. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
Yatomi Y
Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin.
Lee HY; Clair T; Mulvaney PT; Woodhouse EC; Aznavoorian S; Liotta LA; Stracke ML
J Biol Chem; 1996 Oct; 271(40):24408-12. PubMed ID: 8798697
[TBL] [Abstract][Full Text] [Related]
14. Lysophospholipase D and its role in LPA production.
Xie Y; Meier KE
Cell Signal; 2004 Sep; 16(9):975-81. PubMed ID: 15212758
[TBL] [Abstract][Full Text] [Related]
15. Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity.
Ferguson CG; Bigman CS; Richardson RD; van Meeteren LA; Moolenaar WH; Prestwich GD
Org Lett; 2006 May; 8(10):2023-6. PubMed ID: 16671772
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution.
Saunders LP; Cao W; Chang WC; Albright RA; Braddock DT; De La Cruz EM
J Biol Chem; 2011 Aug; 286(34):30130-41. PubMed ID: 21719699
[TBL] [Abstract][Full Text] [Related]
17. Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients.
Nakamura K; Takeuchi T; Ohkawa R; Okubo S; Yokota H; Tozuka M; Aoki J; Arai H; Ikeda H; Ohshima N; Kitamura T; Yatomi Y
Ann Clin Biochem; 2007 Nov; 44(Pt 6):549-56. PubMed ID: 17961310
[TBL] [Abstract][Full Text] [Related]
18. Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis.
Li S; Wang B; Xu Y; Zhang J
Mol Cancer; 2011 Feb; 10():18. PubMed ID: 21314984
[TBL] [Abstract][Full Text] [Related]
19. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate.
Clair T; Aoki J; Koh E; Bandle RW; Nam SW; Ptaszynska MM; Mills GB; Schiffmann E; Liotta LA; Stracke ML
Cancer Res; 2003 Sep; 63(17):5446-53. PubMed ID: 14500380
[TBL] [Abstract][Full Text] [Related]
20. [Function and biological activities of the autotaxin-LPA axis].
Li ZW; Zhao YR; Zhao C; Fu R; Li ZY
Sheng Li Xue Bao; 2011 Dec; 63(6):601-10. PubMed ID: 22193457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
